MARKET IS OPEN
Loading latest tickers...
Market Indices
S&P 500
$7,722.72
+0.73%
NASDAQ 100
$30,807.93
+1.00%
DOW JONES
$51,177.00
+0.49%
NASDAQ Composite
$27,190.86
+1.19%
RUSSELL 2000
$2,815.20
+0.90%
CBOE VIX
$15.31
-6.59%
Sector Heatmap
Technology+1.01%
Financials+0.06%
Healthcare-0.01%
Consumer Cycl+1.13%
Consumer Staples+0.25%
Energy+0.40%
Industrials+0.78%
Materials+0.66%
Real Estate+0.32%
Utilities+0.38%
Comm Services+0.35%
IBO — Impact BioMedical, Inc.
NYSE AmericanImpact BioMedical, Inc.
$5.32
-0.11(-2.02%)
- O
- 5.54
- H
- 5.54
- L
- 5.27
- V
- 10.81K
⏱️ End-of-day dataAs of Oct 2, 2026
Chart
About IBO
Impact BioMedical Inc focuses on the advancement of drug discovery and prevention, inhibition, and treatment of neurological, oncological, and immune-related diseases. The company is also developing open-air defense initiatives, which curb transmission of air-borne infectious diseases, such as tuberculosis and influenza. Its technologies inlcude Linebacker, Laetose, 3F, and Equivir.
IndustryPHARMACEUTICAL PREPARATIONS
SectorNot available
IPO DateSep 16, 2024
Employees8
Stock ExchangeNYSE American
Ticker SymbolIBO
Key Financial Statistics
| Market Cap | $45.45M |
| P/E Ratio | N/A |
| Dividend Yield | None |
| EPS | N/A |
| Beta | N/A |
| 52-Week Range | $0.37 - $7.53 |
| 52-Week Avg Volume | 1.16M |
| VWAP | $5.38 |
| Transactions | 430 |
| Total Recorded Bars | 514 days |